// App-Quantinova.ai

1160 : Evaluating a method validation to deplete, purify and determine the function of IgG4, IgA1 and IgA2 antibodies induced following sublingual immunotherapy in patients with allergic rhinitis

Researchers

Presenter

  • Parkin RV

Principal Investigators

  • Laisuan W

  • Sanver D

  • Scadding GW

  • Larson D

  • Durham SR

  • Shamji MH

Medical Centers

  • Immune Tolerance Network, Bethesda, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Infectious Diseases (ID)

Disease

  • Allergic rhinitis

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin E

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved